ASK Company, the parent company of RIMAN, announced a sponsored research collaboration with Mitragotri Laboratory at the Harvard John A. Paulson School of Engineering and Applied Sciences. The research partnership is expected to validate effectiveness and advance fundamental understanding of the function and action of Araliadiol, the company’s proprietary ingredient derived from Giant BYoungPool.
A formal agreement ceremony was held at the Harvard Science & Engineering Complex to launch the sponsored research initiative, attended by Samir Mitragotri, the Hiller Professor of Bioengineering at Harvard and Hansjorg Wyss Professor of Biologically Inspired Engineering at the Wyss Institute; Mr. Joonghyun Ahn, Founder & Chairman; and Dr. Jiwon Seo, Researcher of RIMAN/ASK Company.
Previous joint studies with Sungkyunkwan University and Konkuk University have clarified the mechanism of action and cell-protective effects of Araliadiol, and a synthetic production process for Araliadiol has begun, giving RIMAN scalability.
RIMAN stated that the Harvard collaboration will leverage organ-on-a-chip technology, a biomimetic platform that replicates human physiological environments on microchips, enabling understanding of biological responses and allowing the research team to evaluate Araliadiol’s skin regeneration and hair growth properties.
“This research collaboration marks a significant milestone in our R&D journey,” said Mr. Joonghyun Ahn, RIMAN/ASK Company Founder & Chairman. “We aim to validate the efficacy of Araliadiol and establish it as a functional ingredient in the beauty market.”
